Ruedi Aebersold joins Insilicos Advisory Board
Seattle, 14 December 2004 - Biomedical software firm Insilicos today announced that proteomics pioneer Ruedi Aebersold has joined Insilicos' Scientific Advisory Board.
Prof. Aebersold is a prominent biologist, who has developed key proteomics techniques. He brings to the Advisory Board unique insights into molecular biology and proteomics.
Insilicos' Scientific Advisory Board represents a deep and formidable understanding of modern biological research. Each member has made important contributions to the advance of biotech. "These scientists have achieved ground-breaking research in systems biology, analytical chemistry, and other areas of science," said Insilicos Chief Scientist Dr. Bryan Prazen. "Our research program benefits from their experience and cutting-edge insight."
"We welcome Professor Aebersold to the Board," said Insilicos President Erik Nilsson. "It's an honor to have such an outstanding group of individuals on our Scientific Advisory Board. These very busy researchers view Insilicos as a good investment of their time. That's a gratifying vote of confidence in our approach."
The Board comprises:
More information on Insilicos' Advisory Board can be found at www.insilicos.com/about.html
Insilicos LLC is a biomarker discovery and diagnostic development company, concentrating on cardiovascular disease.
For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' 'PreClue," and 'Life Science Software' are trademarks of Insilicos LLC.
